IL-15 Antikörper (AA 70-162)
Kurzübersicht für IL-15 Antikörper (AA 70-162) (ABIN7876534)
Target
Alle IL-15 (IL15) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 70-162
-
Verwendungszweck
- Interleukin 15 Antibody / IL15
-
Aufreinigung
- Affinity purified
-
Immunogen
- A human recombinant partial protein (amino acids D70-S162) was used as the immunogen for the Interleukin 15 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the Interleukin 15 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the Interleukin 15 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- IL-15 (IL15) (Interleukin 15 (IL15))
-
Andere Bezeichnung
- Interleukin 15
-
Hintergrund
- Interleukin (IL)-15 is a cytokine with the ability to stimulate the proliferation activity of Th1 and/or Th2 lymphocytes. This gene is mapped to human chromosome 4q31 by fluorescence in situ hybridization. IL-15 is a novel cytokine whose effects on T-cell activation and proliferation are similar to those of interleukin-2 (IL-2), presumably because IL-15 utilizes the beta and gamma chains of the IL-2 receptor. IL-15 can play a role in the initiation and outcome of acute and chronic rejection. Anti-IL-15 therapy in combination with classic immunosuppression therapy might be beneficial in the prevention of acute, and especially chronic, allograft rejection.
-
UniProt
- P40933
-
Pathways
- JAK-STAT Signalweg, Glycosaminoglycan Metabolic Process
Target
-